Puerarin ameliorates 3-nitropropionic acid-induced neurotoxicity in rats: Possible neuromodulation and antioxidant mechanisms

Neurochemical Research

Volumn 39, Issue 2, 2014, Pages 321-332

  Mahdy, Heba M ^a   Mohamed, Mohamed R ^b   Emam, Manal A ^b   Karim, Amr M ^b   Abdel Naim, Ashraf B ^a   Khalifa, Amani E ^a  

^a Ain Shams University   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

3 Nitropropionic acid; Antioxidant; Huntington's disease; Prepulse inhibition; Puerarin

Indexed keywords

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; BODY TEMPERATURE; BODY WEIGHT; BRAIN; ISOFLAVONES; MALE; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONATES; RATS; RATS, WISTAR; STARTLE REACTION;

EID: 84895111382     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1225-7     Document Type: Article

References (71)

1. Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492-498
2. Mirandola SR, Melo DR, Saito A, Castilho RF (2010) 3-Nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions. J Neurosci Res 88:630-639
3. Huang LS, Sun G, Cobessi D, Wang AC, Shen JT, Tung EY, Anderson VE, Berry EA (2006) 3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. J Biol Chem 281:5965-5972
4. Vis JC, de Boer-van Huizen RT, Verbeek MM, de Waal RM, ten Donkelaar HJ, Kremer B (2002) 3-Nitropropionic acid induces cell death and mitochondrial dysfunction in rat corticostriatal slice cultures. Neurosci Lett 329:86-90
5. Tunez I, Santamaria A (2009) Model of Huntington's disease induced with 3-nitropropionic acid. Rev Neurol 48:430-434
6. Tsang TM, Haselden JN, Holmes E (2009) Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease. Neurochem Res 34:1261-1271
7. Misiak M, Singh S, Drewlo S, Beyer C, Arnold S (2010) Brain region-specific vulnerability of astrocytes in response to 3-nitropropionic acid is mediated by cytochrome c oxidase isoform expression. Cell Tissue Res 341:83-93
8. Ross CA, Shoulson I (2009) Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics. Parkinsonism Relat Disord 15(Suppl 3):S135-S138
9. Chen CM (2011) Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease. Chang Gung Med J 34:135-152
10. Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci 27:2803-2820
11. Lim DW, Lee C, Kim IH, Kim YT (2013) Anti-inflammatory effects of total isoflavones from Pueraria lobata on cerebral ischemia in rats. Molecules 18:10404-10412
12. Yeung DK, Leung SW, Xu YC, Vanhoutte PM, Man RY (2006) Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol 552:105-111
13. Zhang Z, Lam TN, Zuo Z (2013) Radix puerariae: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 53:787-811
14. Zhu G, Wang X, Chen Y, Yang S, Cheng H, Wang N, Li Q (2010) Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med 76:1820-1826
15. Li R, Liang T, Xu L, Zheng N, Zhang K, Duan X (2013) Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway. Brain Res 1523:1-9
16. Li R, Zheng N, Liang T, He Q, Xu L (2013) Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. Brain Res 1517:28-35
17. Wang J-W, Wang H-D, Cong Z-X, Zhou X-M, Xu J-G, Jia Y, Ding Y (2014) Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. J Surg Res 186:328-337
18. Pan HP, Li G (2008) Protecting mechanism of Puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia-reperfusion injury. Yakugaku Zasshi 128:1689-1698
19. Xu C, Xu W, Xu H, Xiong W, Gao Y, Li G, Liu S, Xie J, Tu G, Peng H, Qiu S, Liang S (2012) Role of Puerarin in the signalling of neuropathic pain mediated by P2X3 receptor of dorsal root ganglion neurons. Brain Res Bull 87:37-43
20. Gao L, Ji X, Song J, Liu P, Yan F, Gong W, Dang S, Luo Y (2009) Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. Neurol Res 31:402-406
21. Wu HQ, Wang HQ, Zhang B, Zhang GL, Zhang R, Zhang LF (2012) Puerarin decreases hypoxia inducible factor-1 alpha in the hippocampus of vascular dementia rats. Neural Regen Res 7:421-425
22. Chan AS-C, Chen SL, Li Y, Yang D (2006) Puerarin derivatives and their medical uses. In. WO Patent 2,006,042,454
23. Lee EJ, Chen HY, Wu TS, Chen TY, Ayoub IA, Maynard KI (2002) Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J Neurosci Res 68:636-645
24. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181-4192
25. Tadros MG, Khalifa AE, Abdel-Naim AB, Arafa HM (2005) Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype. Pharmacol Biochem Behav 82:574-582
26. Menze ET, Tadros MG, Abdel-Tawab AM, Khalifa AE (2012) Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicology 33:1265-1275
27. Mahdy HM, Tadros MG, Mohamed MR, Karim AM, Khalifa AE (2011) The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Neurochem Int 59:770-778
28. Kumar P, Kalonia H, Kumar A (2010) Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain. Drug Chem Toxicol 33:377-392
29. Binienda ZK, Przybyla BD, Robinson BL, Salem N, Virmani A, Amato A, Ali SF (2006) Effects of l-carnitine pretreatment in methamphetamine and 3-nitropropionic acid-induced neurotoxicity. Ann N Y Acad Sci 1074:74-83
30. Nony PA, Scallet AC, Rountree RL, Ye X, Binienda Z (1999) 3-Nitropropionic acid (3-NPA) produces hypothermia and inhibits histochemical labeling of succinate dehydrogenase (SDH) in rat brain. Metab Brain Dis 14:83-94
31. Seaman RL (2000) Effects of acute systemic 3-nitropropionic acid administration on rat activity and acoustic startle. Neurosci Lett 280:183-186
32. Van den Buuse M, Eikelis N (2001) Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 425:33-41
33. Zagrodzka J, Romaniuk A, Wieczorek M, Boguszewski P (2000) Bicuculline administration into ventromedial hypothalamus: effects on fear and regional brain monoamines and GABA concentrations in rats. Acta Neurobiol Exp 60:333-343
34. Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271-278
35. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77
36. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
37. Bancroft J, Stevens A (1996) Theory and practice of histological techniques. Churchil Livingstone, Edinburgh
38. Tunez I, Tasset I, Perez-De La Cruz V, Santamaria A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules 15:878-916
39. Kumar P, Kalonia H, Kumar A (2010) Huntington's disease: pathogenesis to animal models. Pharmacol Rep 62:1-14
40. Ahuja M, Bishnoi M, Chopra K (2008) Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 244:111-122
41. Bhateja DK, Dhull DK, Gill A, Sidhu A, Sharma S, Reddy BV, Padi SS (2012) Peroxisome proliferator-activated receptor-alpha activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur J Pharmacol 674:33-43
42. Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW (2003) Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Res 994:44-54
43. Pubill D, Verdaguer E, Canudas AM, Sureda FX, Escubedo E, Camarasa J, Pallàs M, Camins A (2001) Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. Br J Pharmacol 132:693-702
44. Chang Y, Hsieh CY, Peng ZA, Yen TL, Hsiao G, Chou DS, Chen CM, Sheu JR (2009) Neuroprotective mechanisms of Puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J Biomed Sci 16:9
45. Swerdlow NR (2013) Update: Studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci Biobehav Rev 37:1150-1156
46. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234-258
47. Lukács A, Szabó A, Vezér T, Papp A (2006) The acute effects of 3-nitropropionic acid on the behavior and spontaneous cortical electrical activity of rats. Acta Neurobiol Exp 66:227-233
48. Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156:194-215
49. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58:192-200
50. Lukacs A, Szabo A, Papp A, Vezer T (2009) Altered open field behavior in rats induced by acute administration of 3-nitropropionic acid: possible glutamatergic and dopaminergic involvement. Acta Biol Hung 60:359-367
51. Prinssen EP, Assie MB, Koek W, Kleven MS (2002) Depletion of 5-HT disrupts prepulse inhibition in rats: dependence on the magnitude of depletion, and reversal by a 5-HT precursor. Neuropsychopharmacology 26:340-347
52. Yeomans JS, Bosch D, Alves N, Daros A, Ure RJ, Schmid S (2010) GABA receptors and prepulse inhibition of acoustic startle in mice and rats. Eur J Neurosc 31:2053-2061
53. Takahashi K, Nagai T, Kamei H, Maeda K, Matsuya T, Arai S, Mizoguchi H, Yoneda Y, Nabeshima T, Takuma K, Yamada K (2007) Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol Psychiatry 62:148-157
54. Kodsi MH, Swerdlow NR (1997) Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease. Neurosci Lett 231:103-107
55. Boyce PJ, Finlay JM (2009) Extracellular dopamine and norepinephrine in the developing rat prefrontal cortex: transient effects of early partial loss of dopamine. Brain Res Bull 79:104-110
56. Kraft JC, Osterhaus GL, Ortiz AN, Garris PA, Johnson MA (2009) In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. Neuroscience 161:940-949
57. Fletcher PJ, Selhi ZF, Azampanah A, Sills TL (2001) Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 24:399-409
58. Segal DS, Mandell AJ (1970) Behavioral activation of rats during intraventricular infusion of norepinephrine. Proc Natl Acad Sci USA 66:289-293
59. Brouillet E, Conde F, Beal MF, Hantraye P (1999) Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 59:427-468
60. Keung WM, Vallee BL (1998) Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria. Proc Natl Acad Sci USA 95:2198-2203
61. Kumar P, Padi SS, Naidu PS, Kumar A (2007) 3-Nitropropionic acid induced neurotoxicity: an animal model for Huntington's disease. J Cell Tissue Res 7:853-860
62. Kumar P, Kumar A (2010) Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res 206:38-46
63. Bueno-Nava A, Gonzalez-Pina R, Alfaro-Rodriguez A, Nekrassov-Protasova V, Durand-Rivera A, Montes S, Ayala-Guerrero F (2010) Recovery of motor deficit, cerebellar serotonin and lipid peroxidation levels in the cortex of injured rats. Neurochem Res 35:1538-1545
64. Greilberger J, Fuchs D, Leblhuber F, Greilberger M, Wintersteiger R, Tafeit E (2010) Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation. Clin Lab 56:441
65. Benzi G, Moretti A (1998) Glutathione in brain aging and neurodegenerative disorders. In: Shaw CA (ed) Glutathione in the nervous system. Taylor & Francis, London, pp 231-256
66. Papandreou MA, Dimakopoulou A, Linardaki ZI, Cordopatis P, Klimis-Zacas D, Margarity M, Lamari FN (2009) Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behav Brain Res 198:352-358
67. Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot E, Bogdanov M, Andersen JK, Jiang D, Beal MF (2000) Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Journal Neurosci Off J Soc Neurosci 20:1-7
68. Lin F, Xie B, Cai F, Wu G (2012) Protective effect of Puerarin on beta-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittelforschung 62:187-193
69. Zhang YB, Du GY, Xiong YL, Zhao Y, Cui HF, Cao CY, Liu S (2008) Protective effects of 3′-methoxy-Puerarin on rat brain suffering from ischemia. Zhongguo Zhong Yao Za Zhi 33:537-540
70. Vis JC, Verbeek MM, De Waal RM, Ten Donkelaar HJ, Kremer HP (1999) 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum. Neuropathol Appl Neurobiol 25:513-521
71. Xu X, Zhang S, Zhang L, Yan W, Zheng X (2005) The Neuroprotection of Puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med 71:585-591